Reading, MA, United States of America

Waan-Jeng Nir

This inventor holds 1 USPTO granted patent. Top assignee: Biotransplant, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Waan-Jeng Nir: Innovator in Genetic Research

Introduction

Waan-Jeng Nir is a notable inventor based in Reading, MA (US). He has made significant contributions to the field of genetic research, particularly through his innovative patent.

Latest Patents

Waan-Jeng Nir holds a patent titled "High efficiency gene trap selection of regulated genetic loci." This patent describes a gene trap construct designed for the identification of genes whose activity is regulated during cellular transition events. The construct includes a downstream sequence that features a functional splice acceptor, a translation stop sequence, and an internal ribosome entry site. Additionally, it contains a promoterless protein coding sequence that encodes at least one polypeptide, providing both positive and negative selection traits. The method outlined in the patent involves introducing the gene trap construct into a cell and observing the expression of the selection traits before and after the transition event. This innovative approach has the potential to advance our understanding of gene regulation.

Career Highlights

Waan-Jeng Nir is currently associated with Biotransplant, Inc., where he continues to work on groundbreaking research in genetics. His expertise and innovative mindset have positioned him as a valuable asset in the field.

Collaborations

Waan-Jeng Nir collaborates with Manfred Baetscher, contributing to the advancement of genetic research through their combined efforts.

Conclusion

Waan-Jeng Nir's contributions to genetic research, particularly through his patent on gene trap constructs, highlight his innovative spirit and dedication to advancing scientific knowledge. His work at Biotransplant, Inc. and collaborations with fellow researchers further emphasize his impact in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…